Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oromucosal Oxytocin and Arginine Vasopressin on Attention to Emotional Faces
NCT07838493Recruiting
- Sponsor
- University of Electronic Science and Technology of China
- Start
- Sep 2026
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
Randomised, double-blind trial comparing oxytocin (OT) group, Arginine Vasopressin (AVP) Group and Placebo (PLC) Group (3 arms). Primary endpoints: Behavioral Performance in the Emotional Face Attention Tasks at 1 hour and BOLD Responses in Predefined Brain Regions and Networks at 1 hour. Started Sep 2026; status: recruiting.
02
Drugs
oxytocinvasopressin
Beyond the preview
Go deeper on NCT07838493.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07838493.